Yankees Infield Notes: McMahon, Volpe
The Yankees intend to get Ryan McMahon some work as a shortstop this spring, manager Aaron Boone tells Greg Joyce of The New York Post and other reporters. They’ll evaluate whether they feel comfortable using him as a potential backup option during the early part of the regular season. Anthony Volpe is beginning the season on the injured list after undergoing postseason labrum surgery. That draws utilityman José Caballero into the lineup at shortstop and leaves them without a clear backup at the position.
Amed Rosario has easily the most shortstop experience of any of their depth infielders. He was an everyday shortstop in Cleveland earlier in his career but struggled defensively and has mostly been pushed off the position. Rosario started 11 games there in 2024 and played all of two innings at the position last year. He’s more of a second/third baseman at this stage of his career, though his biggest appeal off the bench is his ability to hit left-handed pitching. Max Schuemann and Oswaldo Cabrera can cover shortstop but fit better at second or third base, while the out-of-options Jorbit Vivas has never started a professional game at short.
McMahon’s professional experience at shortstop consists of three innings for the 2020 Rockies. He didn’t play there at all in the minor leagues. Listed at 6’2″, 217 pounds and a below-average runner, he’s clearly better suited for third base work. McMahon is an excellent defender at the hot corner, ranking second at the position in Defensive Runs Saved (after Ke’Bryan Hayes) and third in Outs Above Average (behind Hayes and Maikel Garcia) over the last three seasons. His range would be stretched at shortstop, but he should have the hands and arm strength to make the routine plays.
That might be all the Yankees would need to consider him for a temporary backup role. He’d still see the vast majority of his time at third base. If they feel McMahon’s a better fill-in at shortstop than Rosario, they could lift Caballero for a pinch-hitter in key spots and would be better protected in the event of an injury.
That’d also help the roster flexibility. Cabrera and Schuemann still have options remaining. They have three bench jobs committed between Rosario, Paul Goldschmidt and a backup catcher (probably J.C. Escarra). Not needing to carry another shortstop would mean they could have Vivas break camp or consider keeping Jasson Domínguez up as a fourth outfielder. If they want a true shortstop off the bench, they’d probably need to select a non-roster invitee like Braden Shewmake, Zack Short or Paul DeJong onto the 40-man roster.
Ideally, that’ll all be a short-term arrangement. Volpe could return early in the season, pushing Caballero back to the super utility role for which he’s tailor-made. The 24-year-old discussed his rehab with Bryan Hoch of MLB.com, noting that he has begun a hitting progression but isn’t at a point where he can risk diving for ground-balls. Volpe indicated he’s not closing the door on making his season debut before April is out, though Hoch adds that GM Brian Cashman suggested a return in May is likelier.
Volpe has been a below-average hitter in each of his first three seasons in the big leagues. He has shown 20-20 potential but with a subpar batting average and on-base percentage. He was out to a better start last year before suffering the shoulder injury in early May. Even if the offensive regression may have been coming regardless, the injury seemed to take a toll on the other side of the ball. The 2023 Gold Glove winner had a surprisingly poor season defensively. Caballero was the better player down the stretch, but the Yankees are hoping Volpe will more forcefully reclaim the starting job once he’s healthy.
Yankees Injury Notes: Cole, Rodon, Schlittler
The Yankees have received a handful of positive reports regarding their injured starting pitchers, most notably for ace Gerrit Cole. The 35-year-old missed all of 2025 while recovering from Tommy John surgery he underwent in March. Cole is scheduled to face hitters “in a couple weeks,” manager Aaron Boone told reporters, including Greg Joyce of the New York Post. Boone added that Cole could be back in time to pitch in Spring Training games.
Cole is less than a year removed from surgery, so Opening Day was never in play for him. The notion that he could appear in spring action is encouraging and could put him on track to only miss the first month of the season. The 60-day IL remains an option, but if there’s even a small chance Cole could be back within a couple of months, New York will likely avoid that route.
After winning the AL Cy Young in 2023, Cole missed the first half of 2024 with elbow inflammation. He returned for 17 starts to close the season. Elbow concerns popped back up heading into last year, and Cole ended up going under the knife. The veteran has three seasons left on the nine-year, $324MM deal he signed with the Yankees in 2019.
Carlos Rodon was seen playing catch with Cole at today’s spring session. The left-hander had loose bodies removed from his elbow shortly after the 2025 campaign ended. The expectation is that Rodon could return before the end of April. Boone told reporters the lefty is “probably not far behind from the start of the season.”
Rodon recently said he was back throwing eight weeks after his surgery, adding that his mobility is much improved following the procedure. The 33-year-old made a career-high 33 starts this past season. He earned an All-Star bid and finished sixth in AL Cy Young voting, though a rough postseason brought a sour end to his year. Rodon was knocked around for nine earned runs in his two playoff outings.
The lone negative revelation from Thursday was that right-hander Cam Schlittler was managing what was initially described as mid-back inflammation. The young righty took to social media to clarify that it’s a left lat issue. “It’s early, so I just want to make sure I’m on top of it,” Schlittler told reporters, including Bryan Hoch of MLB.com.
Schlittler took a July callup and ran with the opportunity, providing a sub-3.00 ERA across his first 14 big-league starts. He garnered national attention in the postseason. Schlittler delivered eight scoreless innings in a win over Boston in the ALDS. He came through with a quality start against Toronto in the ALCS, though New York lost the game (and the series).
On the hitting side, shortstop Anthony Volpe is scheduled to begin his hitting progression before the end of February. The infielder is recovering from torn labrum surgery. “He is doing well,” Boone told reporters. “Strength is all there in the weight room and stuff like that. He’s got all that back. That’s the thing that took a little while. His range of motion is tremendous.”
Volpe had surgery in early October. Early reports were that he wouldn’t be able to hit for four months. The club has said Volpe will open the season on the IL. Jose Caballero is expected to handle shortstop until Volpe is ready to return.
Photo courtesy of Kim Klement Neitzel and Brad Penner, Imagn Images
Players Who Could Move To The 60-Day IL Once Spring Training Begins
Most of the clubs in the league currently have a full 40-man roster, which means that just about every transaction requires a corresponding move. Some extra roster flexibility is on the way, however. The 60-day injured list goes away five days after the World Series but comes back when pitchers and catchers report to spring training.
Most clubs have a slightly earlier report date this year due to the World Baseball Classic. Last year, the Cubs and Dodgers had earlier report dates because they were had an earlier Opening Day than everyone else as part of the Tokyo Series. Gavin Stone was the first player to land on the 60-day IL in 2025, landing there on February 11th. According to MLB.com, every club has a report date from February 10th to 13th this year.
It’s worth pointing out that the 60 days don’t start being counted until Opening Day. Although a team can transfer a player to the 60-day IL quite soon, they will likely only do so if they aren’t expecting the player back until late May or beyond. A team also must have a full 40-man roster in order to move a player to the 60-day IL.
There are still plenty of free agents still out there, including big names like Framber Valdez, Zac Gallen, Justin Verlander, Chris Bassitt, Lucas Giolito, and more. Perhaps the extra roster flexibility will spur some deals to come together. It could also increase the ability of some clubs to make waiver claims or small trades for players who have been designated for assignment. If a team wants to pass a player through waivers, perhaps they will try to do so in the near future before the extra roster flexibility opens up.
Here are some players who are expected to miss some significant time or who have uncertain recovery timelines from 2025 injuries.
Angels: Anthony Rendon, Ben Joyce
Rendon’s situation is unique. He underwent hip surgery a year ago and missed the entire 2025 season. He is still on the roster and signed through 2026. He and the club have agreed to a salary-deferment plan and he is not expected to be in spring training with the club. His recovery timeline is unclear, but general manager Perry Minasian said earlier this month that Rendon would be “rehabbing at home,” per Alden González of ESPN. If they were going to release him, they likely would have done so by now, so he seems destined for the injured list.
Joyce underwent shoulder surgery in May and missed the remainder of the 2025 season. His current status is unclear. In August, he told Jeff Fletcher of the Orange County Register that he didn’t know if he would be ready for spring training. He would only land on the 60-day IL if the Halos don’t expect him back before the end of May.
Astros: Hayden Wesneski, Ronel Blanco, Brandon Walter
All three of these pitchers underwent Tommy John surgery in 2025. Wesneski was first, with his surgery taking place on May 23rd. Blanco followed shortly thereafter in early June. They will likely be targeting returns in the second half. Walter’s procedure was in September, meaning he will likely miss the entire season. All three should be on the 60-day IL as soon as Houston needs roster spots for other transactions.
Athletics: Zack Gelof
Gelof underwent surgery to repair a dislocated shoulder in September, with the expectation of him potentially being healthy for spring training. At the end of December, general manager David Forst told Martín Gallegos of MLB.com that Gelof would be “a little bit behind” in spring. He would only land on the 60-day IL if the A’s think he’ll be out through late May.
Blue Jays: Jake Bloss
Bloss underwent surgery on the ulnar collateral ligament in his elbow in May. He was on optional assignment at the time and stayed in the minors for the rest of the season. Going into 2026, the Jays could keep him in the minors but they could also call him up and place him on the major league IL. Doing so would open up a roster spot but would also mean giving Bloss big league pay and service time.
Braves: Ha-Seong Kim, AJ Smith-Shawver, Danny Young, Joe Jiménez
Kim recently fell on some ice and injured his hand. He underwent surgery last week, and the expected recovery time is four to five months. The shorter end of that window only goes to mid-May, so perhaps Atlanta will hold off on making a decision until they watch his recovery, especially since they have other guys with clearer injury timelines.
Smith-Shawver underwent Tommy John surgery in June, so he shouldn’t be back until the second half and is therefore a lock for the 60-day IL once Atlanta needs a spot. Young underwent the same procedure in May, so he should also be bound for the IL.
Jimenez is more of a question mark. He missed the 2025 season due to left knee surgery. He required a “cleanup” procedure on that knee towards the end of the season. His timeline isn’t currently clear.
Brewers: None.
Cardinals: None.
Cubs: Justin Steele
Steele will probably be a bit of a borderline case. He underwent UCL surgery in April but it wasn’t a full Tommy John surgery. The Cubs described it as a “revision repair”. Steele had undergone Tommy John in 2017 as a minor leaguer.
Since Steele’s more recent procedure was a bit less serious than a full Tommy John, the club gave an estimated return timeline of about one year, putting him in line to potentially return fairly early in 2026. Given his importance to the Cubs, they would only put him on the 60-day IL if his timeline changes and he’s certain to be out through late May.
Diamondbacks: Corbin Burnes, Lourdes Gurriel Jr., A.J. Puk, Justin Martínez, Blake Walston, Tyler Locklear
The Snakes were hit hard by the injury bug in 2025. Burnes, Walston and Martínez all underwent Tommy John surgery. Burnes and Martínez had their procedures in June, so they should be targeting second-half returns and be easy calls for the 60-day IL. Walston would be a bit more borderline because his surgery was around Opening Day in late March last year. Puk had the slightly less significant internal brace procedure in June, so he could also be a borderline case.
Turning to the position players, Gurriel tore the anterior cruciate ligament in his right knee in September. He required surgery which came with a return timeline of nine to ten months, so he should be out until around the All-Star break.
Locklear should be back sooner. He underwent surgery in October to address a ligament tear in his elbow and a labrum injury in his shoulder. The hope at the time of that procedure was that he would be game ready to go on a rehab assignment around Opening Day and would therefore miss only about the first month. He would therefore only hit the 60-day IL if he doesn’t meet that timeline for some reason.
Dodgers: Brock Stewart
Stewart underwent shoulder debridement surgery in September. His timeline for 2026 isn’t especially clear. He will likely start the season on the IL but it’s unclear if he’ll be out long enough to warrant landing on the 60-day version.
Giants: Randy Rodríguez, Jason Foley
Rodríguez underwent Tommy John surgery in September, so he’s a lock for the 60-day IL and might even miss the entire 2026 campaign. Foley’s status is a bit more murky. He underwent shoulder surgery in May while with the Tigers. Detroit non-tendered him at season’s end, which allowed the Giants to sign him. He is expected back at some point mid-season. The Giants may want to get more clarity on his progress during camp before deciding on a move to the IL.
Guardians: Andrew Walters, David Fry
Neither of these guys is a lock for the 60-day IL. Walters had surgery to repair his right lat tendon in June with a recovery estimate of eight to ten months. Fry underwent surgery in October due to a deviated septum and a fractured nose suffered when a Tarik Skubal pitch hit him in the face. His timeline is unclear. It’s possible one or both could be healthy by Opening Day, so relevant updates may be forthcoming when camps open.
Mariners: Logan Evans
Evans required UCL surgery just last week and will miss the entire 2026 season. He was on optional assignment at the end of 2025, so the Mariners could keep him in the minors. Calling him up and putting him on the big league 60-day IL would open up a 40-man spot but would also involve Evans receiving big league pay and service time for the year.
Marlins: Ronny Henriquez
Henriquez underwent internal brace surgery in December and will miss the entire 2026 season, so he’s a lock for the 60-day IL.
Mets: Tylor Megill, Reed Garrett, Dedniel Núñez
All three of these pitchers underwent Tommy John surgery late in 2025 and are likely to miss the entire 2026 season, making them locks for the 60-day IL. Núñez went under the knife in July, followed by Megill in September and Garrett in October.
Nationals: Trevor Williams, DJ Herz
Williams underwent internal brace surgery in July. That’s a slightly less serious variation of Tommy John but still usually requires about a year of recovery. Herz underwent a full Tommy John procedure in April. Since that surgery usually requires 14 months or longer to come back, both pitchers are likely out until around the All-Star break and therefore bound for the 60-day IL once the Nats need some roster spots.
Orioles: Félix Bautista
Bautista underwent shoulder surgery in August, and the club announced his recovery timeline as 12 months. He’s a lock for the 60-day IL and may miss the entire season if his recovery doesn’t go smoothly.
Padres: Yu Darvish, Jhony Brito, Jason Adam
Darvish underwent UCL surgery in November and will miss the entire 2026 season. Instead of going on the IL, he may just retire, but it seems there are some contractual complications to be ironed out since he is signed through 2028.
Brito and Adam could be borderline cases. Brito underwent internal brace surgery in May of last year. Some pitchers can return from that procedure in about a year. Adam ruptured a tendon in his left quad in early September. In November, he seemed to acknowledge that he wouldn’t be ready for Opening Day. As of now, a trip to the 60-day IL seems unlikely unless he suffers a setback.
Pirates: Jared Jones
Jones required UCL surgery on May 21st of last year. The Bucs announced an expected return timeline of 10 to 12 months. The shorter end of that window would allow Jones to return fairly early in 2026. If it looks like he’ll be on the longer end of that time frame, he could wind up on the 60-day IL.
Phillies: Zack Wheeler
Wheeler underwent surgery to address thoracic outlet syndrome in September, with a timeline of six to eight months. As of now, it seems unlikely Wheeler would require a trip to the 60-day IL, but it depends on how his ramp-up goes. He’s also approaching his 36th birthday, and the Phils could slow-play his recovery.
Rangers: Cody Bradford
Bradford required internal brace surgery in late June of last year. He recently said he’s targeting a return in May. That’s a pretty aggressive timeline, but perhaps the Rangers will delay moving him to the 60-day IL until that plan is strictly ruled out.
Rays: Manuel Rodríguez
Rodriguez underwent flexor tendon surgery in July of last year and is targeting a return in June of this year, so he should be a lock for the 60-day IL.
Reds: Brandon Williamson, Julian Aguiar
Both of these pitchers required Tommy John surgeries late in 2024, Williamson in September and Aguiar in October. They each missed the entire 2025 season. Presumably, they are recovered by now and could be healthy going into 2026, but there haven’t been any recent public updates.
Red Sox: Tanner Houck, Triston Casas
Houck is the most clear-cut case for Boston. He had Tommy John surgery in August of 2025 and will miss most or perhaps all of the 2026 season. Casas is more borderline. He’s still recovering from a ruptured left patellar tendon suffered in May of last year. It doesn’t seem like he will be ready by Opening Day, but his timeline apart from that is murky.
Rockies: Jeff Criswell, Kris Bryant
Criswell required Tommy John surgery in early March of last year. With the normal 14-month recovery timeline, he could be back in May. Anything slightly longer than that would make him a candidate for the 60-day IL. Bryant’s timeline is very difficult to discern. He has hardly played in recent years due to various injuries and is now dealing with chronic symptoms related to lumbar degenerative disc disease. Updates will likely be provided once camp opens.
Royals: Alec Marsh
Marsh missed 2025 due to shoulder problems and is slated to miss 2026 as well after undergoing labrum surgery in November.
Tigers: Jackson Jobe
Jobe required Tommy John surgery in June of last year. He will miss most or perhaps even all of the 2026 season.
Twins: None.
White Sox: Ky Bush, Drew Thorpe, Prelander Berroa
These three hurlers all required Tommy John surgery about a year ago, Bush in February, followed by Berroa and Thorpe in March. Given the normal 14-month recovery period, any of them could return early in 2026, but they could also end up on the 60-day IL if the timeline pushes slightly beyond that.
Yankees: Clarke Schmidt, Gerrit Cole, Carlos Rodón, Anthony Volpe
Schmidt is the only lock of this group. He required UCL surgery in July of last year and should miss the first half of the 2026 season. Cole is recovering from Tommy John surgery performed in March of last year. His target is expected to be late May/early June, so he has a decent chance to hit the 60-day. However, given his importance to the club, the Yankees probably won’t put him there until it’s certain he won’t be back by the middle of May.
Rodón had surgery in October to remove loose bodies in his elbow. He’s expected to be back with the big league club in late April or early May, so he would only hit the 60-day IL if his timeline is pushed. Volpe required shoulder surgery in October. He’s not expected to be ready by Opening Day, but his timeline beyond that doesn’t seem concrete.
Photo courtesy of Allan Henry, Imagn Images
Poll: Will Anthony Volpe Be The Yankees’ Shortstop In 2026?
All things considered, it was a solid year for the Yankees even if it didn’t live up to the perennial World-Series-or-bust expectations of their fans. Despite Gerrit Cole not throwing a single pitch for the team this year and Juan Soto signing elsewhere last winter, they managed to win 94 games thanks to a few key additions like Max Fried and Cody Bellinger, big steps forward from Ben Rice and Trent Grisham, and another MVP-caliber campaign from Aaron Judge.
Not everything went right for the Yankees this year, however, and that’s even ignoring the outcome of the postseason. Some young players who looked like key pieces of the organization’s future this time last year took steps backwards in 2025. While that’s true of Austin Wells and Luis Gil, there’s no player who better exemplifies this than shortstop Anthony Volpe. Volpe was once a consensus top-15 prospect in the sport and even won the Gold Glove in his rookie season with the Yankees, but he’s never quite been able to muster even a league average slash line at the plate.
An 87 wRC+ last year was enough to make him a three-to-four win player thanks to his stellar defense. But this season, the wheels came off. The biggest reason for that is the decline of Volpe’s glove. After being one of the best defenders in all of baseball last year with +14 Outs Above Average, he flipped the script entirely and put up one of the worst performances of any defender in the sport with an OAA of -7.
That’s the sort of defense that might not cut it for a strong bat at the infield’s most important defensive position, so it certainly wasn’t cutting it while Volpe hit a paltry .212/.272/.391 (83 wRC+) in 153 games this year. Some of that can be attributed to poor fortune on batted balls, as his BABIP dropped 50 points relative to the year prior despite a career-high barrel rate of 10.5%. That’s not the whole story, however, as he also hit the fewest line drives of his career this year (15.4%) and struck out at an elevated 25.2% clip. Even his baserunning took a step back, as he went just 18-for-26 on the basepaths after stealing 28 bases in 35 last year.
It’s possible that a partial labrum tear that Volpe spent most of the season playing through is to blame for at least some of his struggles this season. He had a .237/.328/.456 slash and 119 wRC+ through the end of April, just a few days before injuring his shoulder. He hit .205/.255/.374 for a 74 wRC+ from the start of May onwards. He underwent surgery to repair that shoulder but will start 2026 on the injured list.
That might make it seem obvious that the Yankees should either move on from Volpe entirely or at least bring in a player who can handle the majority of shortstop duties while Volpe slips into a smaller role. Things aren’t likely to be that simple, however, in large part due to the weakness of the coming class of shortstops. The prize of this class is Bo Bichette, but he comes with defensive concerns of his own and has long been viewed as a player who would profile better at either second or third base.
The pickings are quite slim outside of Bichette when it comes to shortstops, however. Ha-Seong Kim might opt out of his contract with Atlanta, but he’s coming off an even more difficult season than Volpe. Trevor Story might be a modest upgrade, but he offers limited upside headed into his age-33 season and might not opt out of his contract with the Red Sox. The trade market might feature CJ Abrams but his defense is questionable enough that he may not stick at that spot for much longer. Without another replacement who would be a clear upgrade over Volpe, the Yankees may be forced to choose between either shelling out for a defensively-flawed solution in Bichette or sticking with their internal options.
Those internal options don’t necessarily have to lead to Volpe starting the majority of the Yankees’ games at shortstop next year, though that might be the most likely outcome. Jose Caballero will be back next season and earned plenty of fans in the Bronx for his work on both sides of the ball in 40 games down the stretch. Perhaps he could share time with Volpe at shortstop in the early part of 2026, with the possibility of top-100 prospect George Lombard Jr. stepping up later in the season. Lombard spent most of 2025 at Double-A, so a debut in 2026 isn’t entirely unrealistic. However, he also hit just .215/.337/.358 at the level, suggesting he might need more time to develop before arriving in the show.
How do MLBTR readers view New York’s shortstop situation? Will Volpe be the solution at the position next year? Will they bring in a free agent or trade for someone to handle things? Or will an internal candidate like Caballero or Lombard take the job from Volpe by the end of next year? Have your say in the poll below:
Will Anthony Volpe Finish 2026 As The Yankees' Starting Shortstop?
-
Yes, he will. 51% (2,790)
-
No, he'll be replaced by an external addition. 30% (1,664)
-
No, he'll be replaced by someone already in the organization. 19% (1,020)
Total votes: 5,474
Aaron Judge Will Not Require Elbow Surgery; Rodón, Volpe Expected To Start 2026 On IL
Yankees manager Aaron Boone held a press conference today and provided some notable updates about players on the roster. Outfielder Aaron Judge will not require offseason surgery on his right elbow. However, left-hander Carlos Rodón underwent a procedure to remove loose bodies from his left elbow. He will be no-throw for eight weeks and will likely miss the start of next season. Shortstop Anthony Volpe, who had shoulder surgery this week, won’t be able to hit for four months and won’t be able to dive for six months. Chris Kirschner of The Athletic was among those to relay the updates (tweet one, two and three). General manager Brian Cashman also confirmed, per Greg Joyce of The New York Post, that Volpe will indeed start the season on the injured list.
The news on Judge is obviously good. He was diagnosed with a flexor strain in July. Though his stint on the IL was minimal, he was limited to designated hitter duties in August. This was a bit awkward, as it forced Giancarlo Stanton into the field, surely more than the Yankees had planned on. Judge gradually played the outfield more throughout September and into October.
If Judge had required Tommy John surgery or some other significant elbow operation, that would have had lingering impacts into the 2026 season, though it seems Judge will be expected to be a full-time outfielder again next year. That should allow the Yankees to go into 2026 planning on having Judge in right and Stanton in the DH slot.
The outfield will still be a focus this offseason, however. Trent Grisham is an impending free agent. Cody Bellinger is going to opt out of his contract and hit the open market as well. That leaves Judge and Jasson Domínguez as the two outfield holdovers. A former top prospect, Domínguez has yet to fully break out. 2025 was his largest stretch of big league playing time. He produced roughly league average offense with poor defense.
Per Kirschner, Boone expects Domínguez to be a regular with the Yanks next year but the skipper added the caveat that it depends what moves happen this offseason. The Yanks could pursue reunions with Bellinger and/or Grisham while the free agent market also features names like Kyle Tucker, Harrison Bader and Cedric Mullins. The trade market should feature names like Lars Nootbaar, Alec Burleson, Adolis García and others. Per Jack Curry of the YES Network, Cashman said he would love to have Bellinger back but the Yankees haven’t had any offseason discussions yet. Per Kirschner, Cashman says that prospect Spencer Jones has also put himself in the mix for a job next year, though that also depends on what happens in the offseason.
The Rodón news is obviously less pleasant. It doesn’t appear as though he’s slated for a huge absence, but the Yanks will go into the season with a few guys on the IL. Gerrit Cole had Tommy John surgery in March of last year. He should return at some point in 2026 but Boone confirmed today, per Kirschner, that Cole would not be ready by Opening Day. Clarke Schmidt had his own TJS in July and will be out well into the 2026 campaign.
Those arms could provide nice in-season boosts to the rotation but the Yanks will have to begin the campaign without them. As of right now, the Opening Day rotation projects as Max Fried, Luis Gil, Cam Schlittler and Will Warren. The Yankees will presumably look to bolster that before Opening Day. It’s possible they end up with a crowded group once Rodón and Cole get back on the mound but other injuries are fairly inevitable. The free agent market is headlined by guys like Framber Valdez, Tatsuya Imai, Dylan Cease and Ranger Suárez, while the trade market could feature MacKenzie Gore, Joe Ryan and plenty others.
As for Volpe, it seems Boone still views him as the shortstop once he’s healthy. “Yeah, he’s right in the mix to do that,” Boone said today, per Kirschner. Cashman also admitted today, per Bryan Hoch of MLB.com, that the shoulder issue was impacting Volpe during the season.
That’s backed up by the numbers. Volpe’s defensive metrics dropped significantly this year. He had six Defensive Runs Saved and 14 Outs Above Average in 2024 but 2 DRS and -7 OAA in 2025. His offense finished in a similar spot to previous seasons but he seemed to drop off a cliff once he suffered the injury. He had a .237/.328/.456 slash and 119 wRC+ through the end of April, just a few days before injuring his shoulder. He hit .205/.255/.374 for a 74 wRC+ from the start of May onwards.
Going into 2026, the Yankees could look to external options, though there aren’t surefire answers out there. The free agent market is headlined by Bo Bichette, who is an excellent hitter but a poor defender. Guys like Ha-Seong Kim and Trevor Story could be out there via opt-outs, though there are issues there as well. Kim is coming off a poor season after recovering from shoulder surgery. Story had a bounceback year after his own injury odyssey but he’s about to turn 33 and may not opt out anyway. CJ Abrams may be available in trade but he’s not a great defender either and the bat is inconsistent.
Perhaps the Yankees will let José Caballero hold the job until Volpe is healthy. Caballero played well after being acquired at the deadline. Braden Shewmake is on the roster as depth and the Yanks could bring in some veteran utility types.
Photo courtesy of Brett Davis, Imagn Images
Anthony Volpe Undergoes Shoulder Surgery
Anthony Volpe spent much of the 2025 season playing through a partially torn left labrum, and the Yankees shortstop addressed the problem in the form of a surgical procedure yesterday, according to Joel Sherman and Greg Joyce of the New York Post. The exact timeline for Volpe’s recovery isn’t yet clear, but if everything goes normally, a source tells Sherman/Joyce that Volpe would be ready for the start of the 2026 season.
The injury to Volpe’s non-throwing shoulder occurred in early May, when Volpe said he heard “a pop” in his shoulder after diving to try and snag a grounder. What seemed like a minor issue at the time ended up being a lingering source of discomfort throughout the season, and Volpe received two cortisone shots (one at the All-Star break, one in September) to try and manage the pain. The Yankees never placed Volpe on the injured list, but he didn’t play for the week following his second shot in September.
It is impossible to think that the injury didn’t contribute to Volpe’s tough season. He hit .212/.272/.391 with 19 home runs over 596 plate appearances, resulting in just an 83 wRC+. While these numbers weren’t far off what Volpe produced when healthy in 2023-24, it is worth noting that April (prior to the shoulder issue) was far and away Volpe’s best offensive month of 2025. The bigger impact may have come defensively, as Volpe dropped to -7 Outs Above Average and +2 Defensive Runs Saved — middling metrics for a shortstop who was a Gold Glove winner in 2023 and a finalist for the award again in 2024.
Volpe’s struggles made him a particular target for fan criticism in the Bronx, and something of an avatar for the fanbase’s frustrations towards GM Brian Cashman and manager Aaron Boone. There has yet to be any sign that Volpe’s starting job might be in danger, though Jose Caballero provided a big spark to the lineup after being acquired at the trade deadline, and getting a good dose of time at shortstop while Volpe was sidelined in September.
More will be known about Volpe’s recovery process in the coming weeks, but if he has any kind of setback, the Yankees could be encouraged to pursue at least a depth option at shortstop this winter if Caballero isn’t entrusted with the starting job. There will certainly be more speculation about whether or not the Yankees could land a bigger-name shortstop in a larger shake-up for the position, but it doesn’t feel like the Yankees would be inclined to move on entirely from Volpe, due to his former top-prospect status and the team’s three remaining years of control over his services. Volpe is arbitration-eligible for the first time this winter, and projected to earn $3.9MM in 2026.
Yankees Notes: Judge, Bellinger, Volpe
Aaron Judge‘s massive postseason performance made it easy to forget he’s been dealing with a flexor strain in his right elbow since July. The slugger had multiple hits in all but one game across the first two rounds of the playoffs. Judge engineered a defining postseason moment in Game 3 against Toronto, smashing a game-tying homer off Louis Varland.
With the Yankees now headed into the offseason, Judge was asked about the plan for his ailing elbow. “We’ll definitely do some work on it and get it right,” Judge told reporters, including Chris Kirschner of The Athletic. When asked about surgery specifically, Judge remained noncommittal. “I’m not a doctor. I don’t know.”
The flexor strain forced Judge to the IL in late July. It was a minimum stint on the IL, but he was unable to play the field upon returning. Judge spent all of August at DH. He made it back to his familiar home in right field on September 5. Judge bounced between right field and DH for the final month of the season. In the playoffs, he played exclusively in the field, with Giancarlo Stanton manning the DH spot in all seven games.
Initial tests did not reveal any ulnar collateral ligament damage for Judge. His recovery from surgery to address the flexor strain, if he were to go that route, would not be as long as for a more serious elbow injury like a UCL tear.
Anthony Volpe was similarly tight-lipped about offseason surgery for his shoulder injury. “I anticipated playing another month and then reassessing then. So nothing’s [decided] … we’re going to figure it out,” Volpe told reporters, including Bryan Hoch of MLB.com.
Volpe partially tore the labrum in his shoulder back in May. He didn’t go on the IL with the injury, but his performance suffered. Volpe slashed a solid .237/.328/.456 through April. His numbers tumbled to .205/.255/.374 over the final five months of the season. Volpe got off to a strong start in the postseason, going 4-for-11 with a home run in the Wild Card round against Boston. He collapsed in the ALDS, managing just one hit in 15 at-bats. Volpe struck out 11 times in the four games against Toronto.
Depending on the severity of the tear, Volpe could elect surgery and still be ready for the 2026 season. Shohei Ohtani tore the labrum in his non-throwing shoulder during the World Series in 2024. He made it back in time for spring training this year.
While Volpe never hit the IL with the shoulder issue, he did miss time in mid-September after receiving a cortisone injection. Midseason acquisition Jose Caballero started six straight games at shortstop from September 10-15. Caballero receded to a bench role once Volpe was deemed healthy, but he did endear himself to Yankees fans with a walk-off single to clinch a postseason bid in the final week of the season. Caballero is under team control through 2029 and could factor into New York’s middle infield plans depending on the health of Volpe.
No matter what Judge and Volpe decide on the surgery front, they’ll definitely be back with the team next season. The same can’t be said for Cody Bellinger, who is facing a decision of his own. Bellinger can opt out of the final year of his current contract with the Yankees. He’d be leaving $20MM on the table ($25MM salary next year but with a $5MM buyout) in pursuit of a longer, potentially more lucrative deal in free agency.
Hoch passed along comments from Bellinger about the pending opt-out decision. As has been the theme with these Yankees, Bellinger didn’t say much. “Obviously, things to discuss with family and the agent and the business side of it all. But tonight, I’m just going to soak it all in and just be a part of the group one more time.”
Bellinger signed his current three-year, $80MM contract with the Cubs ahead of the 2024 season. He could’ve opted out of the deal this past offseason, but declined. Bellinger was then dealt to the Yankees. He slugged 29 home runs in his first year in pinstripes, his most since his 2019 NL MVP season. Bellinger also stayed healthy, topping 600 plate appearances for just the third time in his career. He’s widely expected to opt out of the final year of his deal.
Cashman: Yankees “Believe In” Anthony Volpe Despite “Tough Stretch”
Anthony Volpe‘s underwhelming season has made the shortstop a topic of controversy in the Bronx, and more attention was generated this week when it was revealed that Volpe has been playing with a small tear in his left shoulder labrum since May 3. Trying to play through this shoulder problem has clearly impacted Volpe’s performance — not only has he hit .197/.248/.378 in 418 plate appearances since suffering the injury, Volpe’s formerly excellent defense has drastically fallen off.
Speaking with ESPN’s Jorge Castillo and other reporters on Friday, Yankees GM Brian Cashman noted Volpe’s “tough stretch” and said that “this isn’t the season we expected or he expected.” That said, Cashman gave a vote of confidence to Volpe, saying that the 2025 season “doesn’t change our viewpoint of what he’s capable of,” and that he is still the Yankees’ choice at shortstop going forward.
“He’s someone that we can count on and we believe in….I think he’s a really talented guy and I think he has a chance to be a positive impact, obviously,” Cashman said.
Volpe was hitting significantly better (.239/.333/.453) in his first 135 plate appearances of the season pre-injury, so it could be that his labrum tear prevented a potential breakout year. Still, Volpe’s full-season numbers aren’t far off the .228/.288/.373 slash line he posted over 1290 PA in his first two Major League seasons, so it isn’t as if struggles at the plate are a new problem for the 24-year-old.
Outsized expectations have followed Volpe ever since his emergence as one of baseball’s top prospects, and the Yankees’ decision to debut him as their Opening Day shortstop in 2023. While the team itself has always been quick to downplay the “next Derek Jeter” hype, the Yankees’ immediate installation of Volpe in an everyday role has stood in stark contrast to the club’s more infrequent usage of most other top minor leaguers in recent years. If anything, Volpe’s critics are sure to argue that Cashman’s continued confidence in Volpe is part of the problem, and that the Yankees should be more open to upgrading at shortstop.
While Cashman has made some rather blunt critiques of other New York players in the past, it only makes sense for the GM to continue his public support of Volpe, and there isn’t any reason to yet suspect that the Yankees aren’t viewing Volpe’s rough year as anything but a by-product of his shoulder injury. Since Volpe is only entering arbitration eligibility this coming offseason, his three remaining years of pretty inexpensive team control make him an intriguing asset on a team loaded with big salaries and a hefty luxury tax bill. If Volpe is able to get healthy and break out as, in Cashman’s words, “a quality, above-average regular shortstop in the game,” that’s a major boost for the Yankees on every front.
Still, finding another inexpensive shortstop candidate could change the equation, and one such player may have already been found in Jose Caballero. Acquired from the Rays at the trade deadline, Caballero has hit .263/.358/.439 in 68 PA in the pinstripes, which far and away represents the best offensive stretch of his three MLB seasons. The utilityman has also pitched in at both corner outfield slots, second base, and third base, but most of Caballero’s time has come at shortstop in the wake of Volpe’s increased missed time.
Volpe hasn’t played since Tuesday after receiving a cortisone shot in his ailing shoulder, paving the way for Caballero to step into regular shortstop duty. Boone told Castillo and company that “we’ll see” about who plays shortstop when Volpe is ready to return, which hints that the Yankees could be considering a timeshare at the position.
The longer-term issue of Volpe’s health is also a lingering question. Cashman said more will be known once Volpe receives more tests, and while the GM “wouldn’t rule…out” an offseason surgery, “as of right now, there’s no surgery recommended. There’s not even an IL recommended.” Should Volpe indeed end up going under the knife, he’d very likely miss some time and perhaps an extended amount of the 2026 season, leaving the Yankees in need of another shortstop.
Anthony Volpe Playing Through Partial Labrum Tear
Anthony Volpe has been the Yankees’ regular shortstop for close to three years now. Lately, he has struggled enough that José Caballero has taken some playing time. It’s possible that health is playing a role in Volpe’s downturn. He injured his left shoulder back in early May. Today, Joel Sherman of The New York Post reports that the shoulder discomfort has lingered since then and Volpe received a cortisone shot in that shoulder yesterday.
Yankees manager Aaron Boone spoke to the media before tonight’s game and provided more details, per Brendan Kuty of The Athletic and Bryan Hoch of MLB.com. Boone confirmed the report of the cortisone shot and said Volpe has a small labrum tear in his shoulder. When the injury was discovered in May, they believed it was an old injury that he could play through. He has since aggravated it multiple times, including on Sunday. He also had a cortisone shot during the All-Star break, per Kuty. The Yanks don’t believe he needs an IL stint now. He will have another MRI after the season.
At the time of that injury, Volpe said he heard a “pop” in his shoulder but quickly felt better. “It happened quick and it was scary, but after that, I felt OK and I felt like I had my strength,” Volpe said at the time. “I’ve never really had anything else pop or dislocate or anything like that, so I have nothing to compare it to.”
Greg Joyce of The New York Post writes that the Yankees have consistently downplayed the shoulder injury even though Volpe is usually wrapped up in ice after most games. Just yesterday, Boone brushed off the problem, per Chris Kirschner of The Athletic.
“I think early on after that, maybe a little bit,” the skipper said, when asked if Volpe’s shoulder has been impacting his performance. “I think it’s something that’s also improved over the course of the year. I feel like, even lately, it’s been in as good of a place as it’s been. I don’t necessarily think that’s the case, but he’s also a very tough kid and a gamer. I don’t think so, but I guess shouldn’t rule it out.”
As noted by Sherman, there’s a stark contrast between Volpe’s pre- and post-injury numbers. On May 4th, he had a .233/.326/.442 batting line. That translated to a 114 wRC+, indicating he was 14% better than league average at that point in the season. Since then, he has a .197/.248/.378 line and 70 wRC+.
It’s also possible that the injury is impacting Volpe defensively. He was credited with 15 Defensive Runs Saved in 2023 and six last year but is at just one here in 2025. Outs Above Average is even more notable. That metric gave Volpe a +1 grade in 2023 and +14 last year but has dropped him all the way to -9 here in 2025. Volpe made eight throwing errors in 2023 and nine last year but already has 13 in 2025, in a smaller sample of playing time.
Despite the declining numbers, Boone has stuck by Volpe. A couple of weeks ago, the skipper said that he still considered Volpe to be the club’s shortstop while Caballero was considered a “10th man” who could bounce around to various positions in a utility capacity.
More recently, it’s possible there’s been a shift. Caballero has started in place of Volpe in two of the past five games. It’s possible the cortisone shot leads to Volpe missing some more time, as players usually require a few days’ rest after receiving such injections.
On the one hand, it’s somewhat encouraging that Volpe’s struggles have a possible explanation. On the other hand, it’s a less than ideal situation at this time of year when every game is meaningful. The Yanks currently hold a Wild Card spot but they are in a tight battle with clubs like the Red Sox, Mariners, Rangers, Guardians, Royals and Rays. The Yanks are also surely hoping to chase down the Blue Jays for the division lead, currently trailing by just three games.
Sending Volpe to the injured list or simply sitting him for a few games could perhaps help his shoulder woes a bit but that would leave the club a bit thinner at shortstop as they play meaningful games. There would also be the risk of Volpe getting rusty after a layoff and not having time to get into a better groove.
For now, it seems Caballero could benefit from a bit more playing time. He has a solid .239/.345/.413 line since being acquired at the deadline but he has a career .226/.313/.335 slash and 89 wRC+. Even if his hitting is subpar, his glovework is good and he’s one of the top base stealers in the majors. If Volpe does require a stint on the IL, the Yanks could perhaps recall Braden Shewmake to serve as a glove-first backup to Caballero.
Photo courtesy of John Jones, Imagn Images
Boone: Yankees Still Consider Volpe Starting Shortstop
Anthony Volpe is out of the lineup as the Yankees open their series against the Nationals. It’s the second straight game in which José Caballero gets the start at shortstop. New York is giving the scuffling Volpe what amounts to a two-day mental reset. However, manager Aaron Boone made clear this evening that the Yankees aren’t moving the third-year infielder to the bench.
“I view Anthony as our shortstop,” Boone told reporters (including Chris Kirschner of The Athletic). The skipper confirmed that Volpe would be back in the lineup tomorrow and continue playing regularly from that point. He added that the Yanks consider Caballero their “10th man” and will keep bouncing him around the diamond in a utility role (via Bryan Hoch of MLB.com).
Volpe is hitting .208/.274/.400 across 509 plate appearances. He had a productive April but carries a .198/.255/.382 batting line in 96 games since the beginning of May. Volpe has never hit for a high average or reached base at a strong clip. He’s tied with Dansby Swanson for eighth among shortstops with 18 home runs, but he hasn’t been a productive overall hitter. The struggles have magnified over the past six weeks, as he’s batting .171 with a .203 on-base percentage going back to July 1. Among 253 hitters with at least 100 plate appearances in that stretch, only Miami’s Dane Myers has a lower batting average. No one has a worse on-base mark.
The offensive drought is magnified by his uncharacteristic issues on the other side of the ball. Volpe won a Gold Glove as a rookie in 2023; he was a finalist for that honor last year. He trailed only Swanson and Ezequiel Tovar in combined Defensive Runs Saved among shortstops over those two seasons. Statcast’s Outs Above Average had him tied for seventh. Even with the OBP deficiencies, Volpe’s power and plus defense made him a valuable all-around player. The Yankees presumably felt he was on a similar trajectory as Swanson, an eventual everyday shortstop on a World Series team who received a $177MM free agent contract.
Volpe’s defensive grades have tanked this year as well. DRS has him right around average. Statcast has him five runs below par, tying him for fourth worst at the position. Volpe has committed 17 errors, matching his career high with another month to play. Only Elly De La Cruz (19) has been charged with more this season.
Caballero, acquired from the Rays at the deadline, has gotten out to a fantastic start to his Yankee tenure. He’s hitting .286 with more walks than strikeouts in 15 games. Caballero has stolen six bases in seven tries and is up to an MLB-high 40 steals between Tampa Bay and New York. He led the American League with 44 steals last year, though he was also caught a league leading 16 times. Caballero is a plus runner and versatile defender but is unlikely to remain an above-average hitter over a large sample. He owns a .227/.313/.337 batting line in more than 1000 career plate appearances.
There’s no argument that Caballero hasn’t been the more productive player of late. Still, the 24-year-old Volpe entered the season as New York’s expected franchise shortstop. Caballero is soon to turn 29 and is established as a high-end utility player. The Yankees can still find playing time for him on most days. He’s a right-handed complement to Jazz Chisholm Jr. and Ryan McMahon at second and third base, respectively. They’re tolerating Giancarlo Stanton in right field for as long as Aaron Judge is unable to throw at game speed, but they’ll frequently kick Caballero into the outfield later in games for defensive purposes.